Concepedia

Michael Case

MC

Statistics

Publications

46

Citations

4.4K

H-Index

28

Active since

1991

Affiliations

Eli Lilly (United States)(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

The University of Texas Health Science Center at San Antonio

Harvard University

Michael Case is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and neurology.

Top concepts

Publications per year

1991–2024

46

Publications

46

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text

The Science Performance of JWST as Characterized in Commissioning

Jane R. Rigby, Marshall D. Perrin, Michael W. McElwain et al. · Publications of the Astronomical Society of the Pacific · 2023 · 383 citations · Full text

, , +13

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Eric Siemers, Karen Sundell, Christopher Carlson et al. · Alzheimer s & Dementia · 2015 · 362 citations · Full text

Trial of Solanezumab in Preclinical Alzheimer’s Disease

Reisa A. Sperling, Michael Donohue, Rema Raman et al. · New England Journal of Medicine · 2023 · 321 citations · Full text

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine

Peter J. Goadsby, Linda Wietecha, Ellen B. Dennehy et al. · Brain · 2019 · 264 citations · Full text

, , +16

1–5 of 46